IP Library › Assignment 026682/0684
Patent Assignment
Reel/Frame 026682/0684

Security Agreement

Recorded: 2011-08-01 Pages: 5
Assignor
NANIRX THERAPEUTICS, INC.
Executed: 2011-07-01
Assignees
NGN BIOMED OPPORTUNITY I, L.P.
369 LEXINGTON AVENUE, 17TH FLOOR, NEW YORK, NEW YORK, 10017
NGN BIOMED OPPORTUNITY I GMBH & CO. BETEILIGUNGS KG
369 LEXINGTON AVENUE, 17TH FLOOR, NEW YORK, NEW YORK, 10017
GBR INVESTMENTS, LLC
2045 MAIDSTONE FARM ROAD, ANNAPOLIS, MARYLAND, 21409
NEW YORK CITY INVESTMENT FUND, L.L.C.
ONE BATTERY PARK PLAZA, 5TH FLOOR, NEW YORK, NEW YORK, 10004
Covered Properties (7)
Treatment of Cancer with Immunostimulatory Hiv Tat Derivative Polypeptides
Vaccines and Immunotherapeutics Derived from the Human Immunodeficiency Virus (Hiv) Trans-Activator of Transcription Protein for the Treatment and Prevention of Hiv Disease
Patent: 6,667,151 →
Application: 09/636,057 →
Tat-Based Immunomodulatory Compositions and Methods of Their Discovery and Use
Patent: 7,927,580 →
Application: 10/598,978 →
Publication: US 2008/0155703
Vaccines and Immunotherapeutics Derived from the Human Immunodeficiency Virus (Hiv) Transactivator of Transcription Protein for the Treatment and Prevention of Hiv Disease
Patent: 8,323,928 →
Application: 11/277,456 →
Publication: US 2006/0160183
Tat-Based Tolerogen Compositions and Methods for Making and Using Same
Application: 12/395,975 →
Publication: US 2009/0202585
Tat-Based Vaccine Compositions and Methods of Making and Using Same
Application: 12/405,086 →
Publication: US 2009/0181045
Treatment of Cancers with Immunostimulatory HIV TAT Derivative Polypeptides
Patent: 8,530,431 →
Application: 12/730,043 →
Publication: US 2011/0009336
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 13, 2000
From: COHEN, DAVID I.
To: INIST, INC.
Reel/Frame 011362/0883 →
Assignment of Assignor's Interest Mar 4, 2002
From: COHEN, DAVID I.
To: INIST, INC.
Reel/Frame 012694/0799 →
Assignment of Assignor's Interest May 21, 2007
From: COHEN, DAVID I.
To: NANIRX, INC.
Reel/Frame 019317/0439 →
Assignment of Assignor's Interest May 22, 2007
From: COHEN, DAVID I.
To: NANIRX, INC.
Reel/Frame 019328/0575 →
Assignment of Assignor's Interest Nov 9, 2007
From: COHEN, DAVID I.
To: INIST, INC.
Reel/Frame 020093/0355 →
Change of Name Nov 9, 2007
From: INIST, INC.
To: NANIRX, INC.
Reel/Frame 020094/0149 →
Change of Name Mar 2, 2009
From: INIST, INC.
To: NANIRX, INC.
Reel/Frame 022330/0995 →
Assignment of Assignor's Interest Mar 2, 2009
From: COHEN, DAVID I.
To: INIST, INC.
Reel/Frame 022330/0728 →
Assignment of Assignor's Interest Mar 17, 2009
From: COHEN, DAVID I.
To: NANIRX, INC.
Reel/Frame 022407/0264 →
Assignment of Assignor's Interest Feb 2, 2011
From: COHEN, DAVID I.
To: NANIRX, INC.
Reel/Frame 025768/0541 →
Security Agreement Feb 23, 2011
From: NANIRX THERAPEUTICS, INC.
To: GBR INVESTMENTS, LLC; NGN BIOMED OPPORTUNITY I, L.P.; NGN BIOMED OPPORTUNITY I GMBH & CO. BETEILIGUNGS KG; NEW YORK CITY INVESTMENT FUND, L.L.C.
Reel/Frame 025838/0876 →
Assignment of Assignor's Interest Dec 31, 2011
From: NANIRX THERAPEUTICS, INC.
To: PIN PHARMA, INC.
Reel/Frame 027467/0136 →